BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aramaki T, Moriguchi M, Bekku E, Asakura K, Sawada A, Endo M. Comparison of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter arterial chemoembolization of hepatocellular carcinoma: Comparison of EPIR and MPT for TACE of HCC. Hepatol Res 2013;43:475-80. [DOI: 10.1111/j.1872-034x.2012.01100.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Kakiuchi Y, Sakata S, Nakamura K, Okabayashi H, Akaike K, Tokunaga T, Saeki S, Fujii K, Ichiyasu H. Acute Exacerbation of Idiopathic Interstitial Pneumonia in a Patient with Hepatocellular Carcinoma after Transcatheter Arterial Therapy Using Miriplatin. Intern Med 2019;58:1329-33. [PMID: 30626817 DOI: 10.2169/internalmedicine.1446-18] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Shi Q, Chen D, Zhou C, Liu J, Huang S, Yang C, Xiong B. Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study. Cancer Manag Res 2020;12:5461-8. [PMID: 32753963 DOI: 10.2147/CMAR.S255960] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]